ATI RN
ATI Hematologic System Quizlet Questions
Question 1 of 5
Which is not associated with hypersplenism:
Correct Answer: C
Rationale: Step-by-step rationale: 1. Hypersplenism is characterized by splenomegaly (A), causing sequestration and destruction of blood cells. 2. Pancytopenia (B) results from excessive destruction of blood cells in the enlarged spleen. 3. Hypercellular bone marrow (C) is not directly associated with hypersplenism; it is a compensatory response to increased blood cell destruction. 4. Splenectomy (D) can reverse the effects of hypersplenism by removing the source of blood cell destruction. Therefore, the correct answer is C as hypercellular bone marrow is a secondary response to hypersplenism, not a direct association.
Question 2 of 5
Busulfan therapy lead to all except:
Correct Answer: C
Rationale: The correct answer is C: optic neuritis. Busulfan therapy is known to cause adverse effects such as hyperpigmentation, pulmonary fibrosis, and bone marrow suppression due to its cytotoxic effects. However, optic neuritis is not a reported side effect of busulfan therapy. Optic neuritis is more commonly associated with other medications or conditions affecting the optic nerve. Therefore, the absence of optic neuritis as a known side effect of busulfan therapy makes choice C the correct answer.
Question 3 of 5
Best tit modality in CML is:
Correct Answer: B
Rationale: The best treatment modality for chronic myeloid leukemia (CML) is allogenic bone marrow transplantation (BMT) because it offers the potential for cure by replacing the abnormal cells with healthy donor cells. This is the only option that can provide long-term disease control and potential cure for CML. Hydroxyurea (choice A) is a cytotoxic drug used for symptom control but does not target the underlying cause. Interferon alpha (choice C) can help control the disease but is less effective in achieving long-term remission compared to BMT. Radiotherapy (choice D) is not a standard treatment for CML and is not curative.
Question 4 of 5
Splenectomy is contraindicated in:
Correct Answer: C
Rationale: Splenectomy is contraindicated in bone marrow (BM) failure because the spleen plays a crucial role in hematopoiesis and immune function. Removing the spleen can worsen BM failure by disrupting hematopoiesis and exacerbating the existing condition. In pyruvate kinase deficiency, splenectomy can improve symptoms by reducing hemolysis. In immune thrombocytopenic purpura (ITP), splenectomy may be considered as a treatment option to increase platelet count. Angiogenic myeloid metaplasia does not have a direct contraindication for splenectomy, as the primary concern is the underlying disease pathology, not the surgical intervention.
Question 5 of 5
A nursing student is caring for a patient with acute myeloid leukemia who is preparing to undergo induction therapy. In preparing a plan of care for this patient, the student should assign the highest priority to which nursing diagnoses?
Correct Answer: B
Rationale: The correct answer is B: Risk for Infection. During induction therapy for acute myeloid leukemia, the patient's immune system is compromised, increasing the risk of infections. Priority is given to preventing infections to avoid complications. Activity Intolerance (A) may be a concern but is secondary to infection risk. Acute Confusion (C) may occur but is not as critical as preventing infections. Risk for Spiritual Distress (D) is important but addressing physical needs like infection prevention takes precedence for this patient population.